Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
Recruiting now · Not applicable
Conditions studied: Cancer, Advanced Cancer, Advanced Solid Tumor, Mental Health Issue, Behavior Disorders
In brief
The purpose of this study is to determine whether a consultation with a Personalized Therapeutics Clinic, or PTC, will help participants lower the risk for side effects (drug-drug interactions and drug-gene interactions) when taking many medications and help providers improve prescribing decisions for participants. A PTC is a clinical that will test your genes to gather information about your health that may help guide prescribing advice and offer you new information about your prescriptions. Doctors leading this study will look for variations (differences) in your genes that may suggest that you are at greater risk of having side effects or a greater chance of benefiting from certain medications. Individuals in this study will participate for roughly 9 months.
Key facts
- Study ID
- NCT05166694
- Run by
- University of Chicago
- People needed
- 1300
- Starts
- 2022-11-30
- Expected to finish
- 2027-11-01
- Last updated by the study team
- 2026-03-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult participants cared for by a participating provider at University of Chicago Medical Center.
- Participants must be at least 18 years of age.
- Participants prescribed 5 or medication medications and taking a perpetrator drug or a drug with actionable pharmacogenomic information.
- Exclusion Criteria for Participants
- Participants who have undergone, or are being actively considered for, liver or kidney transplantation.
- Participation in another pharmacogenomic study.
- Participants who have previously received genotyping from another source.
- Inability to understand and give informed consent to participate.
- Inclusion of Women, Minorities, and Other Underrepresented Populations Individuals of all races and ethnic groups and genders are eligible for this trial.
Where it is running
- University of Chicago Medicine — Chicago, Illinois, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.